JOHN SHAFFER, assistant professor in the Department of Human Genetics at Pitt Public Health, and Seth Weinberg, an associate professor in the Department of Oral Biology at the School of Dental Medicine, received a grant award of $1.7 million from the National Institute of Dental and Craniofacial Research (NIDCR) for their project, “The Genetic Architecture of Human Facial Morphology.”
To mark his installation as the Philip Hallen Endowed Chair in Community Health and Social Justice, BCHS’s STEVEN ALBERT will revisit Rousseau’s 1754 Discourse on the Origin and Foundations of Inequality Among Men , or “Second Discourse.” We have moved beyond early philosophical speculation to an emerging science of inequality, where the emergence of hierarchy can be explored experimentally. Health disparities can be viewed through this same len...
A new way to collect and organize data could be the answer to tackling the years-long opioid overdose epidemic. The University of Pittsburgh’s Program Evaluation and Research Unit (PERU) is working with Pennsylvania officials to standardize death data from overdose victims. The purpose of the project is to provide more detailed reporting in real-time that could help show where the problem areas are. A large number of staffers are Pitt Public Heal...
HPM's LAUREN BORRELLI plans to utilize her fellowship to build industry-specific knowledge of the Korean health care market. As a Korean-American, she is excited to be able to connect her cultural heritage to her professional career.
Every year our school faculty members gather for continuing education and updates on pertinent policies. They work hard all year, and students regularly tell us that it is these are the people that make their degree years so positive.
CNBC - New California legislation prompts Nightly Business Report ’s Meg Tirrell to ask HPM’s WALLID GELLAD about California Governor Brown’s bill requiring pharma to announce 60 days before a rise of more than 16 percent over two years, and to provide justification for the hike. Locate Gellad’s comments at 17:37–18:05.
TIME MAGAZINE - Granting top honors to Pittsburgh's East Liberty & Lawrenceville neighborhoods, Time's MONEY rankings cite the steel town's reinvigorated cool factor and influx of new bars, restaurants, and hotels. They signal out the Ace Hotel (and cool bar), housed in a former YMCA where guests can play cornhole, ping pong, and video games in the old-school gym.
CNN - Despite any advantages Xtampza may have (harder to crush and abuse), “people still get addicted to oral pills. They can still take too much. They can still overdose,” said HPM’s WALLID GELLAD, co-director of the University of Pittsburgh’s Center for Pharmaceutical Policy and Prescribing. Gellad believes that there'’s more to Cigna’s new policies than a desire to combat the opioid crisis.
It is known that high blood pressure in one’s 50s puts a person at risk for dementia in later life. It's now know that hypertension in the 30s and 40s has a similar effect, but only in women. LEWIS KULLER, epidemiology professor emeritus, talks about why this unexpected research finding might be true.
This September, the Department of Infectious Diseases and Microbiology recognized student research poster winners at the annual IDM research day. Students winners were awarded prizes in various categories during the next day's IDM annual meeting and picnic at North Park.
Saumyadipta Pyne will join the Public Health Dynamics Laboratory (PHDL) as its scientific director and will also serve as an associate professor in the Department of Biostatistics, both at the University of Pittsburgh Graduate School of Public Health, beginning October 1. “I am very excited that Dr. Pyne will be joining PHDL with an associate professor appointment in our biostatistics department,” commented Shyamal Peddada, chair of the Departmen...
Congratulations to alumnus CHARLES JOHN SCHLEUPNER (IDM ’68), who has been appointed to the Dean’s Council on Advancement for the Virginia Tech Carilion School of Medicine. The council is a committee of volunteers created to advance the stature of the medical school by providing guidance, assistance, advocacy, and philanthropic investment in support of the school’s strategic objectives.
The Henry L. Hillman Foundation is re-upping its commitment to cultivate cancer research and care by committing an additional $30 million over the next 10 years to the University of Pittsburgh and the UPMC Hillman Cancer Center.
Some of our favorite HPM alumni connected at Clyde’s of Gallery Place on September 27, 2017. Back Row: Jenny Huang, Alexandra Dulin, Alex Nason, David Tye, Mark Faccenda, Kevin Broom, Mark Roberts; Front Row: Deborah Backman, Nikita Sharma, Sally Caine Leathers, Kelly Delmore, Kristin Lazzara, and Kush Banjeree.
A new handheld device could someday help cancer surgeons figure out what to cut and what to leave alone in real time. The MasSpecPen employs water, plastic tubing, and a mass spectrometer. It's the latest in engineer's effort to speed up the pace at which samples collected during operations are processed for clinically valuable information.
A radiation oncologist, and widow whose husband died of cancer, studies the effects of financial strain on cancer patients.
Ian Toothill, 47, a personal trainer from London, has stage IV bowel cancers. Earlier this month, he reached the summit of Mt. Everest. "It's a way of changing the narrative, asserting control," explains Ellen Ormond, PhD, of the Center for Counseling and Cancer Support at the University of Pittsburgh...
AMERICAN JOURNAL OF MANAGED CARE - An article by alumna INMACULADA (INMA) HERNANDEZ (HPM ’16) discusses the impact of the outcomes-based pricing arrangements proposed by Amgen on the pricing of PCSK9 inhibitor therapy, and provides recommendations for payers on the design of outcomes-based contracts. She is an assistant professor at Pitt’s School of Pharmacy. Her research explores the intersection of pharmaceutical health services and outcomes re...
Researcher SUZANNE GOLLIN, Department of Human Genetics, has been reappointed as a member of the Pennsylvania Cancer Control, Prevention, and Research Advisory Board. This was confirmed by the Senate on September 20, 2017. She is pictured here with an image of tumor cell biomarkers.
WALL STREET JOURNAL - One of the largest managers of pharmaceutical benefits in the U.S. says it will start limiting the duration and dose of some prescriptions for opioid painkillers, in an effort to combat widespread addiction. The restrictions, based on CDC recommendations published last year, could cause some debate. WALID GELLAD, physician and HPM assistant professor, said the restrictions for chronic pain could cause cumbersome paperwork an...